Skip to main content

Pharmaceutical Trademark Guide 2017/2018 – A Global Guide – Canada Chapter

September 8, 2016

Susan Keri, Jennifer McKenzie and Meghan Dillon discuss upcoming developments affecting pharmaceutical trademarks in Canada. Various legislative and regulatory changes are expected to bring both benefits and challenges to applicants in all industries by 2018.

This article first appeared in Pharmaceutical Trademarks: A Global Guide 2017/2018, a supplement to World Trademark Review, published by Globe Business Media Group - IP Division.

To view the guide in full, please go to

To read the Canadian chapter, please download the PDF below.

Content shared on Bereskin & Parr’s website is for information purposes only. It should not be taken as legal or professional advice. To obtain such advice, please contact a Bereskin & Parr LLP professional. We will be pleased to help you.


Susan Keri Susan Keri
B.A., LL.B.
416.957.1165  email Susan Keri
Jennifer McKenzie Jennifer McKenzie
B.A. (Hons.), LL.B.
416.957.1628  email Jennifer McKenzie
Meghan Dillon Meghan Dillon
B.Sc. (Psych.), LL.B.
416.957.1160  email Meghan Dillon